Skip to main content
Fig. 3 | Malaria Journal

Fig. 3

From: Profiling of the anti-malarial drug candidate SC83288 against artemisinins in Plasmodium falciparum

Fig. 3

Ring stage susceptibility of different P. falciparum strains to dihydroartemisinin and SC83288. a Ring survival assay (RSA) scores of NF54, NF54ART, Dd2, and Dd2SC to dihydroartemisinin (DHA). b RSA scores to SC83288. Mean ± SEM of 3–6 independent determinations. Statistical significance was evaluated using the one way ANOVA Holm-Sidak test. ***p < 0.001; n.s. not significant

Back to article page